Drug recall D-0492-2023
Product
Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
Reason for recall
cGMP Deviations
Lots and codes
Lot #: a) J0665197-120522, Exp. Date 12/31/2023; J0642497-082722, Exp. Date 09/30/2023 J0638552-080922, Exp. Date 08/31/2023. Lot #: b) B1808799-081622, Exp. Date 05/31/2024
Recall details
- Recalling firm
- RemedyRepack Inc., Indiana, PA
- Quantity
- a) 58 bottles, b) 6 bottles
- Distribution
- RemedyRepack distributed product to consignees nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 20, 2023
- Terminated
- October 19, 2023
Related products
- NDC 70518-1560 Doxazosin · Doxazosin Mesylate 2 mg/1 · REMEDYREPACK INC.